Interwest Partners X Lp - Net Worth and Insider Trading

Interwest Partners X Lp Net Worth

The estimated net worth of Interwest Partners X Lp is at least $242 Million dollars as of 2024-04-25. Interwest Partners X Lp is the 10% Owner of Tesaro Inc and owns about 3,071,701 shares of Tesaro Inc (TSRO) stock worth over $230 Million. Interwest Partners X Lp is the 10% Owner of PMV Pharmaceuticals Inc and owns about 6,469,356 shares of PMV Pharmaceuticals Inc (PMVP) stock worth over $11 Million. Interwest Partners X Lp is also the 10% Owner of Obalon Therapeutics Inc and owns about 126,741 shares of Obalon Therapeutics Inc (OBLN) stock worth over $386,560. Besides these, Interwest Partners X Lp also holds Eiger BioPharmaceuticals Inc (EIGRQ) , Doximity Inc (DOCS) . Details can be seen in Interwest Partners X Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Interwest Partners X Lp has not made any transactions after 2021-06-28 and currently still holds the listed stock(s).

Transaction Summary of Interwest Partners X Lp

To

Interwest Partners X Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Interwest Partners X Lp owns 9 companies in total, including PMV Pharmaceuticals Inc (PMVP) , Avedro Inc (AVDR) , and Obalon Therapeutics Inc (OBLN) among others .

Click here to see the complete history of Interwest Partners X Lp’s form 4 insider trades.

Insider Ownership Summary of Interwest Partners X Lp

Ticker Comapny Transaction Date Type of Owner
PMVP PMV Pharmaceuticals Inc 2021-03-24 10 percent owner
AVDR Avedro Inc 2019-11-21 10 percent owner
OBLN Obalon Therapeutics Inc 2019-08-06 10 percent owner
EIGRQ Eiger BioPharmaceuticals Inc 2018-10-18 10 percent owner
IVTY Invuity Inc 2015-06-18 10 percent owner
TSRO Tesaro Inc 2013-08-05 other: Former 10% Owner
RSLS Reshape Lifesciences Inc 2018-08-23 10 percent owner
DOCS Doximity Inc 2021-11-12 10 percent owner
BRZE Braze Inc 2022-02-08 10 percent owner

Interwest Partners X Lp Latest Holdings Summary

Interwest Partners X Lp currently owns a total of 5 stocks. Among these stocks, Interwest Partners X Lp owns 3,071,701 shares of Tesaro Inc (TSRO) as of July 3, 2012, with a value of $230 Million and a weighting of 95.25%. Interwest Partners X Lp owns 6,469,356 shares of PMV Pharmaceuticals Inc (PMVP) as of September 25, 2020, with a value of $11 Million and a weighting of 4.52%. Interwest Partners X Lp also owns 126,741 shares of Obalon Therapeutics Inc (OBLN) as of August 6, 2019, with a value of $386,560 and a weighting of 0.16%. The other 2 stocks Eiger BioPharmaceuticals Inc (EIGRQ) , Doximity Inc (DOCS) have a combined weighting of 0.07% among all his current holdings.

Latest Holdings of Interwest Partners X Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSRO Tesaro Inc 2012-07-03 3,071,701 74.96 230,254,707
PMVP PMV Pharmaceuticals Inc 2020-09-25 6,469,356 1.69 10,933,212
OBLN Obalon Therapeutics Inc 2019-08-06 126,741 3.05 386,560
EIGRQ Eiger BioPharmaceuticals Inc 2018-10-18 45,411 3.80 172,448
DOCS Doximity Inc 2021-06-28 0 23.91 0

Holding Weightings of Interwest Partners X Lp


Interwest Partners X Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Interwest Partners X Lp has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 444,444 shares on July 3, 2012, which cost Interwest Partners X Lp around $6 Million.

According to the SEC Form 4 filings, Interwest Partners X Lp has made a total of 2 transactions in PMV Pharmaceuticals Inc (PMVP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in PMV Pharmaceuticals Inc is the acquisition of 55,000 shares on September 25, 2020, which cost Interwest Partners X Lp around $990,000.

According to the SEC Form 4 filings, Interwest Partners X Lp has made a total of 1 transactions in Obalon Therapeutics Inc (OBLN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Obalon Therapeutics Inc is the acquisition of 8,333 shares on August 6, 2019, which cost Interwest Partners X Lp around $100,000.

More details on Interwest Partners X Lp's insider transactions can be found in the Insider Trading History of Interwest Partners X Lp table.

Insider Trading History of Interwest Partners X Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Interwest Partners X Lp Trading Performance

GuruFocus tracks the stock performance after each of Interwest Partners X Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Interwest Partners X Lp is 6.78%. GuruFocus also compares Interwest Partners X Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Interwest Partners X Lp within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Interwest Partners X Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Interwest Partners X Lp

Average Return

-14.57%

Average return per transaction

Outperforming Transactions

20%

1 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12.23 6.78 -12.71 -14.57 -28.52 -9.98
Relative Return to S&P 500(%) -15.68 0.97 -24.14 -35.28 -38.75 -21.28

Interwest Partners X Lp Ownership Network

Ownership Network List of Interwest Partners X Lp

No Data

Ownership Network Relation of Interwest Partners X Lp


Interwest Partners X Lp Owned Company Details

What does PMV Pharmaceuticals Inc do?

Who are the key executives at PMV Pharmaceuticals Inc?

Interwest Partners X Lp is the 10 percent owner of PMV Pharmaceuticals Inc. Other key executives at PMV Pharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , Chief Medical Officer Leila Alland , and SVP & Regulatory Affairs and QA Deepika Jalota .

PMV Pharmaceuticals Inc (PMVP) Insider Trades Summary

Over the past 18 months, Interwest Partners X Lp made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 87,786 shares made by Orbimed Advisors Llc , a net sale of 6,291 shares made by Leila Alland , and a net sale of 4,104 shares made by Deepika Jalota .

In summary, during the past 3 months, insiders sold 0 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 98,181 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 98,181 shares.

PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PMV Pharmaceuticals Inc Insider Transactions

No Available Data

Interwest Partners X Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Interwest Partners X Lp. You might contact Interwest Partners X Lp via mailing address: C/o Interwest Partners, 467 First Street Suite 201, Los Altos Ca 94022.

Discussions on Interwest Partners X Lp

No discussions yet.